Usted buscó: hind (Inglés - Maltés)

kaiser-i-hind butterflies
friefet kaiser-i-hind

owned or controlled by designated irano hind
proprjetà jew ikkontrollata minn irano hind indikata

lameness was also observed when the hind leg was used as the injection site.
meta l-injezzjoni ngħatat fis-sieq ta’ wara, l-annimali dehru jzappu.

half-carcases shall be marked on the skin of the hind shank or the ham.
nofsijiet ta' karkassi għandhom jiġu mmarkati fuq il-ġilda tal-ġenb ta' wara jew fuq il-koxxa.

neurological signs are frequently seen, such as a staggering hind limb gait, in coordination of movement, and convulsions.
jidhru spiss sinjali newroloġiċi, bħal mixja bi tkaxkira tas-saqajn ta' wara, fil-kordinament tal-movimenti u l-konvulsjonijiet.

cangrelor produced dose-related foetal growth retardation characterised by increased incidences of incomplete ossification and unossified hind limb metatarsals in rats.
cangrelor ipproduċa dewmien fit-tkabbir tal-fetu marbut mad-doża, ikkaratterizzat minn żieda fl- inċidenzi ta’ ossifikazzjoni inkompleta u metatarsals mhux ossifikati tar-riġlejn ta’ wara fil-firien.

to cover the intended clinical use of beromun, ilp experiments were performed in hind legs of healthy rats using different doses in the same tasonermin concentration as in the clinical situation in the human.
sabiex jiġi kopert l-użu kliniku li għalih huwa maħsub beromun, saru esperimenti ta’ ilp fuq is- saqajn ta’ wara ta’ firien b’saħħithom fejn intużaw dożi differenti ta’ tasonermin li huma l-istess dożi bħal dawk li jiġu mogħtija fis-sitwazzjonijiet kliniċi tal-bniedem.

in that case, care must be taken to ensure that animals which are hostile to one another are not transported together or where they are transported together, that they have their hind hoofs unshod.
f’dak il-każ, għandha tingħata kura biex jiġi assigurat li l-annimali li huma ostili lejn xulxin ma jinġarrux flimkien jew meta jinġarru flimkien, ikollhom id-dwiefer ta’ wara mhux imniegħla.

intradermal administration of 0.2 ml per animal, preferably at the sides of the neck, along the muscles of the back or in the hind leg using a multi-dose needle-free injection device for intradermal application of liquids suitable to deliver a “jet-stream” volume of vaccine (0.2ml ± 10%) through the epidermal layers of the skin.
amministrazzjoni minn ġol-ġilda ta' 0.2ml kull annimal preferibbilment fil-ġnub tal-għonq, mall- muskoli ta' wara jew fis-sieq ta' wara billi tuża apparat tal-injezzjoniet għall-ħafna dożi, mingħajr labar għall-applikazzjoni minn ġol-ġilda ta' likwidi, adattat li jagħti volum tal-vaċċin (0.2ml ± 10%) "jet-stream" minn ġos-saffi epidermali tal-ġilda .